Sandoz adds 10 biosimilars as Sandoz stock reaches CHF 32.9 billion value

Published on 10/20/2026 at 10:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sandoz stock costs EUR 82.09 on October 20, 2026, with a CHF 32.9 billion market value. Henlius deal adds 10 assets for USD 322 million.

Deal structure and upcoming date

Sandoz adds up to 10 biosimilar assets under a USD 322 million collaboration dated October 20, 2026.
A preliminary antitrust settlement dated October 19, 2026 requires a USD 400 million payment.
Sandoz stock trades at EUR 82.09 at 10:32 a.m. CEST at Lang & Schwarz on October 20, 2026.

Sandoz, CH1243598427, Illustration mit AI erstellt.

Sandoz adds up to 10 biosimilar assets through a USD 322 million collaboration with Shanghai Henlius Biotech, while Sandoz stock trades at a CHF 32.9 billion market value as of October 20, 2026. pharmaphorum reported the deal on October 20, 2026.

Ten biosimilars broaden the pipeline

The collaboration gives Sandoz access to a group of late-stage and commercial-stage biosimilar candidates. The USD 322 million consideration and the potential addition of 10 assets make the agreement material for a company whose portfolio is built around generic medicines and biosimilars.

Three dated events shape the picture

On October 12, 2026, Barclays maintained a Buy rating and a CHF 93.00 price target for Sandoz, according to Markets Insider. On October 19, 2026, a Connecticut federal court gave preliminary approval to a USD 400 million settlement involving Sandoz Inc., as reported by VitalLaw. On October 20, 2026, Sandoz announced the Henlius collaboration involving up to 10 biosimilar assets and USD 322 million.

What comes next for reporting?

The next scheduled company date is October 27, 2026, when Sandoz is listed to release its third-quarter sales and revenue update, according to MarketScreener. That report will provide the next measured test of pipeline expansion against operating performance.

Stock valuation and Swiss listing

Sandoz stock was quoted at CHF 76.58 on the SIX Swiss Exchange on October 19, 2026, according to MarketScreener, while the euro reference price stood at EUR 82.09 at Lang & Schwarz on October 20, 2026. The company is included in the SMI, and its market capitalization was CHF 32.9 billion as of October 20, 2026.

At Lang & Schwarz, Sandoz stock was trading at EUR 82.09 on October 20, 2026 at 10:32 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Sandoz stock.